Search Results for 'sof hcv'

sof hcv published presentations and documents on DocSlides.

Sofosbuvir in HCV-

Sofosbuvir in HCV-

by mitsue-stanley

HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

by pasty-toler

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

by danika-pritchard

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

by briana-ranney

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

Sofosbuvir + Ribavirin in HCV Recurrence

Sofosbuvir + Ribavirin in HCV Recurrence

by williams

Following Liver Transplantation. Phase 2. Charlton...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

by pamella-moone

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Simplified HCV Therapy in 2018

Simplified HCV Therapy in 2018

by phoebe-click

This program is s. upported. by educational gran...

Treatment of Chronic HCV

Treatment of Chronic HCV

by lam

with Direct-Acting Antivirals (DAAs). www.hcvguide...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

by sophia

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

by ahmir

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

by robaut

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

by giovanna-bartolotta

VALENCE Trial. Phase . 3. Treatment. Naïve and ...

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

by summer

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

by sophia2

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

by alida-meadow

SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...

Sofosbuvir-Velpatasvir in Genotype 2

Sofosbuvir-Velpatasvir in Genotype 2

by stefany-barnette

ASTRAL-2*. Phase 3. . Treatment. . Naïve &...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by trish-goza

in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

by debby-jeon

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

by giovanna-bartolotta

Genotype . 2. . or 3 . FUSION. Trial. Phase . ...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by jane-oiler

(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Slides for today’s webinar are available on the CIHS website at:

Slides for today’s webinar are available on the CIHS website at:

by tatiana-dople

Slides for today’s webinar are available on the...

Andrew I. Aronsohn, MD Associate Professor of Medicine

Andrew I. Aronsohn, MD Associate Professor of Medicine

by alida-meadow

University of Chicago. Chicago, Illinois. Challen...

2014: HIV, HCV, and HBV

2014: HIV, HCV, and HBV

by kittie-lecroy

Update. David Spach, MD. Professor of Medicine,...

ALLY-3 Design Objective SVR

ALLY-3 Design Objective SVR

by mitsue-stanley

12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...

by aaron

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

by tawny-fly

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

by aaron

qd. Non-randomised. Open-label. N =. 21. W12. SV...

Newest Drugs for Hepatitis C

Newest Drugs for Hepatitis C

by tawny-fly

Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

by giovanna-bartolotta

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

by tatyana-admore

. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...

by luanne-stotts

+ Ribavirin to Prevent Post-Transplant HCV Recur...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

Trent W Nichols

Trent W Nichols

by cheryl-pisano

Hepatitis-2015. Orlando. , USA. July 20 - 22 20...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...